Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes. | Biomedicines | 2020 | 33050356 | PubTator, text mining | PubMed |
| lncRNA involved in triptonide-induced cytotoxicity in mouse germ cells. | Reprod Toxicol | 2020 | 33045310 | PubTator, text mining | PubMed |
| National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract. | Eur J Med Genet | 2020 | 33039684 | PubTator, text mining | PubMed |
| Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. | Biochim Biophys Acta Rev Cancer | 2020 | 33035640 | PubTator, text mining | PubMed |
| Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome. | Diagnostics (Basel) | 2020 | 33027913 | PubTator, text mining | PubMed |
| Structural Aspects of DNA Repair and Recombination in Crop Improvement. | Front Genet | 2020 | 33024442 | PubTator, text mining | PubMed |
| Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome. | Nat Commun | 2020 | 33020491 | PubTator, text mining | PubMed |
| Curcumin Regulates ERCC1 Expression and Enhances Oxaliplatin Sensitivity in Resistant Colorectal Cancer Cells through Its Effects on miR-409-3p. | Evid Based Complement Alternat Med | 2020 | 33014113 | PubTator, text mining | PubMed |
| Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. | Sci Rep | 2020 | 33009475 | PubTator, text mining | PubMed |
| Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational Profiling. | Cancers (Basel) | 2020 | 33007869 | PubTator, text mining | PubMed |
| Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer. | J Cancer Immunol (Wilmington) | 2020 | 33000102 | PubTator, text mining | PubMed |
| Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets. | Commun Biol | 2020 | 32999426 | PubTator, text mining | PubMed |
| Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation. | Cancer Chemother Pharmacol | 2020 | 32997196 | PubTator, text mining | PubMed |
| Features of DNA Repair in the Early Stages of Mammalian Embryonic Development. | Genes (Basel) | 2020 | 32992616 | PubTator, text mining | PubMed |
| Transcriptome and Gene Fusion Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript Involved in Colorectal Cancer. | Int J Mol Sci | 2020 | 32992457 | PubTator, text mining | PubMed |
| Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice. | Elife | 2020 | 32990597 | PubTator, text mining | PubMed |
Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups. | Cancers (Basel) | 2020 | 32987854 | PubTator, text mining | PubMed |
| Epigenetic based synthetic lethal strategies in human cancers. | Biomark Res | 2020 | 32974031 | PubTator, text mining | PubMed |
| Characteristics of cancer susceptibility genes mutations in 282 patients with gastric adenocarcinoma. | Chin J Cancer Res | 2020 | 32963463 | PubTator, text mining | PubMed |
| Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants. | Genes (Basel) | 2020 | 32957448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=59